AR-231,453

From WikiMD's Wellnesspedia

AR-231,453 is a drug that acts as a potent and selective agonist for the G protein-coupled receptor GPR119, which is mainly expressed in the pancreas and gastrointestinal tract. It is being researched for potential use in the treatment of diabetes.

Mechanism of action[edit | edit source]

AR-231,453 works by activating the GPR119 receptor. This receptor is found in the pancreas and gastrointestinal tract, where it plays a role in regulating glucose metabolism. When AR-231,453 binds to this receptor, it stimulates the release of insulin and glucagon-like peptide-1 (GLP-1), both of which help to control blood sugar levels.

Potential therapeutic uses[edit | edit source]

The main potential use for AR-231,453 is in the treatment of diabetes. By stimulating the release of insulin and GLP-1, it could help to improve blood sugar control in people with this condition. However, more research is needed to confirm its effectiveness and safety.

Research[edit | edit source]

AR-231,453 is currently in the early stages of research. Initial studies have shown promising results, but further trials are needed to fully understand its potential benefits and risks.

See also[edit | edit source]


AR-231,453 Resources

Find a healthcare provider anywhere in the world quickly and easily!

Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.


Contributors: Prab R. Tumpati, MD